| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/30/2023 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 4.6k | $0.36 | $1.6k | | 06/30/2023 |
| 03/31/2023 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 1.2k | $1.75 | $2k | | 03/31/2023 |
| 12/30/2022 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 410 | $5.04 | $2.1k | | 12/30/2022 |
| 09/30/2022 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 605 | $3.32 | $2k | | 09/30/2022 |
| 06/30/2022 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 4.3k | $0.50 | $2.2k | | 06/30/2022 |
| 06/14/2022 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 40k | $0.44 | $17.6k | | 06/14/2022 |
| 06/09/2022 | TENAX THERAPEUTICS, INC. | TENX | Grant | Stock Option (right to buy) | 5k | $0.62 | $3.1k | | 06/09/2022 |
| 03/31/2022 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 3k | $0.72 | $2.2k | | 03/31/2022 |
| 12/31/2021 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 737 | $1.70 | $1.3k | | 12/31/2021 |
| 12/15/2021 | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Grant | Common Stock | 2k | $0.00 | $0 | | 12/15/2021 |
| 12/10/2021 | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Grant | Common Stock | 2k | $0.00 | $0 | | 12/10/2021 |
| 11/10/2021 | Avalo Therapeutics, Inc. | CERC | Grant | Stock Option (Right to Buy) | 80k | $2.28 | $182.4k | | 11/10/2021 |
| 06/10/2021 | TENAX THERAPEUTICS, INC. | TENX | Grant | Stock Option (right to buy) | 6.2k | $2.00 | $12.5k | | 06/10/2021 |
| 12/12/2019 | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Grant | Common Stock | 2k | $0.00 | $0 | | 12/12/2019 |
| 01/04/2019 | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Purchase | Common Stock | 1.5k | $3.39 | $5k | By Meadowlark Management LLC | 01/04/2019 |
| 08/27/2018 | 9 METERS BIOPHARMA, INC. | INNT | Purchase | Common stock | 47 | $4.90 | $230.3 | By Meadowlark Management LLC | 08/24/2018 |
| 08/27/2018 | 9 METERS BIOPHARMA, INC. | INNT | Purchase | Common stock | 253 | $4.96 | $1.3k | By Meadowlark Management LLC | 08/24/2018 |
| 08/27/2018 | 9 METERS BIOPHARMA, INC. | INNT | Purchase | Common stock | 100 | $4.94 | $494 | By Meadowlark Management LLC | 08/24/2018 |
| 08/24/2018 | 9 METERS BIOPHARMA, INC. | INNT | Purchase | Common stock | 500 | $4.85 | $2.4k | By Meadowlark Management LLC | 08/24/2018 |
| 08/24/2018 | 9 METERS BIOPHARMA, INC. | INNT | Purchase | Common stock | 100 | $4.85 | $485 | By Meadowlark Management LLC | 08/24/2018 |
| 08/24/2018 | 9 METERS BIOPHARMA, INC. | INNT | Purchase | Common stock | 400 | $4.99 | $2k | By Meadowlark Management LLC | 08/24/2018 |
| 03/15/2018 | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Purchase | Common Stock | 5.7k | $3.50 | $20k | By Meadowlark Management LLC | 03/15/2018 |
| 03/15/2018 | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Grant | Common Stock | 5.7k | $3.50 | $20k | By Meadowlark Management LLC | 03/15/2018 |
| 10/16/2017 | NeuBase Therapeutics, Inc. | OHRP | Grant | Stock Option (right to buy) | 170k | $0.67 | $113.9k | | 10/16/2017 |
| 04/08/2014 | NeuBase Therapeutics, Inc. | OHRP | Purchase | Common Stock, $0.0001 par value | 5.5k | $10.25 | $56.4k | | 04/08/2014 |
| 05/09/2011 | Furiex Pharmaceuticals, Inc. | FURX | Grant | Stock Options (to buy) | 46k | $15.00 | $690k | | 05/09/2011 |